Details of the Drug Formulaction

General Information of Drug Formulation (ID: F14018)

• Formulation Name: Metyrapone 250 mg capsule
• Company: Laboratoire HRA Pharma

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Metyrapone	(DMI7FVQ)	Cushing disease	5A70	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ethyl vanillin	(E00178)	8467	Flavoring agent
Glycerin	(E00026)	753	Antimicrobial preservative; Emollient; Flavoring agent; Humectant; Lubricant; Plasticizing agent; Solvent; Suppository base; Tonicity agent; Viscosity-controlling agent
Propylparaben sodium	(E00567)	23679044	Antimicrobial preservative
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent